Nuveen’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.6M | Buy |
37,814
+7,547
| +25% | +$513K | ﹤0.01% | 2449 |
|
|
2026
Q1 | $2.27M | Buy |
30,267
+176
| +0.6% | +$14.4K | ﹤0.01% | 2230 |
|
|
2025
Q4 | $2.35M | Sell |
30,091
-1,188
| -4% | -$96.4K | ﹤0.01% | 2219 |
|
|
2025
Q3 | $2.66M | Sell |
31,279
-79,268
| -72% | -$6.35M | ﹤0.01% | 2181 |
|
|
2025
Q2 | $8.64M | Sell |
110,547
-9,706
| -8% | -$715K | ﹤0.01% | 1602 |
|
|
2025
Q1 | $8.7M | Sell |
120,253
-640
| -0.5% | -$53.7K | ﹤0.01% | 1635 |
|
|
2024
Q4 | $10.7M | Buy |
120,893
+59,190
| +96% | +$5.27M | ﹤0.01% | 1561 |
|
|
2024
Q3 | $5.22M | Buy |
61,703
+67
| +0.1% | +$5.95K | ﹤0.01% | 1968 |
|
|
2024
Q2 | $5.7M | Buy |
61,636
+23,678
| +62% | +$2.39M | ﹤0.01% | 1880 |
|
|
2024
Q1 | $4.28M | Hold |
37,958
| – | – | ﹤0.01% | 2069 |
|
|
2023
Q4 | $3.54M | Buy |
37,958
+347
| +0.9% | +$30.6K | ﹤0.01% | 2137 |
|
|
2023
Q3 | $3.45M | Buy |
37,611
+2,332
| +7% | +$250K | ﹤0.01% | 2052 |
|
|
2023
Q2 | $4.28M | Sell |
35,279
-269
| -0.8% | -$29K | ﹤0.01% | 2000 |
|
|
2023
Q1 | $3.48M | Sell |
35,548
-347
| -1% | -$33.1K | ﹤0.01% | 2088 |
|
|
2022
Q4 | $2.91M | Sell |
35,895
-2,274
| -6% | -$191K | ﹤0.01% | 2212 |
|
|
2022
Q3 | $2.9M | Sell |
38,169
-20
| -0.1% | -$1.92K | ﹤0.01% | 2194 |
|
|
2022
Q2 | $4.17M | Sell |
38,189
-758
| -2% | -$80.5K | ﹤0.01% | 2059 |
|
|
2022
Q1 | $3.79M | Buy |
38,947
+429
| +1% | +$40.9K | ﹤0.01% | 2202 |
|
|
2021
Q4 | $3.61M | Sell |
38,518
-4,772
| -11% | -$478K | ﹤0.01% | 2283 |
|
|
2021
Q3 | $4.79M | Sell |
43,290
-16,674
| -28% | -$1.9M | ﹤0.01% | 2237 |
|
|
2021
Q2 | $6.95M | Buy |
59,964
+8,342
| +16% | +$958K | ﹤0.01% | 2075 |
|
|
2021
Q1 | $5.37M | Buy |
51,622
+323
| +0.6% | +$40.2K | ﹤0.01% | 2139 |
|
|
2020
Q4 | $6.17M | Sell |
51,299
-2,730
| -5% | -$275K | ﹤0.01% | 1961 |
|
|
2020
Q3 | $4.69M | Sell |
54,029
-2,787
| -5% | -$240K | ﹤0.01% | 1952 |
|
|
2020
Q2 | $4.6M | Buy |
56,816
+254
| +0.4% | +$18.5K | ﹤0.01% | 1941 |
|
|
2020
Q1 | $3.9M | Buy |
56,562
+1,363
| +2% | +$144K | ﹤0.01% | 1850 |
|
|
2019
Q4 | $6.31M | Sell |
55,199
-13,974
| -20% | -$1.74M | ﹤0.01% | 1861 |
|
|
2019
Q3 | $9.03M | Sell |
69,173
-5
| -0% | -$651 | ﹤0.01% | 1638 |
|
|
2019
Q2 | $8.48M | Buy |
+69,178
| New | +$7.95M | ﹤0.01% | 1708 |
|
|
2014
Q3 | – | Sell |
-31,390
| Closed | -$1.07M | – | 1636 |
|
|
2014
Q2 | $1.07M | Buy |
31,390
+2,285
| +8% | +$73.7K | 0.01% | 1127 |
|
|
2014
Q1 | $1.01M | Sell |
29,105
-7,795
| -21% | -$259K | 0.01% | 1140 |
|
|
2013
Q4 | $1.3M | Sell |
36,900
-616
| -2% | -$20.2K | 0.01% | 971 |
|
|
2013
Q3 | $1.17M | Buy |
37,516
+61
| +0.2% | +$1.8K | 0.01% | 1028 |
|
|
2013
Q2 | $1.03M | Buy |
+37,455
| New | +$990K | 0.01% | 1013 |
|
Other funds holding USPH
BG
CCM
SAM
Nuveen's USPH Position: Q2 2026 in Review
Nuveen increased its US Physical Therapy (USPH) stake by 25% in Q2 2026, buying an estimated $513K and bringing the position to 37,814 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2449.
Nuveen first reported a position in USPH in Q2 2013 and has held it in 34 quarters since. The position peaked at $10.7M in Q4 2024. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.
- Nuveen held 37,814 shares of US Physical Therapy worth $2.6M as of Q2 2026.
- Nuveen bought 7,547 US Physical Therapy shares in Q2 2026, an estimated $513K.
- US Physical Therapy made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2449 holding.
- Nuveen first reported a position in US Physical Therapy in Q2 2013 and has held it in 34 quarters since.
- Nuveen's US Physical Therapy position peaked at $10.7M in Q4 2024.
- 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.